Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors
Clinical trial NCT04087018 · COMPLETED
Trial details
- NCT number
- NCT04087018
- Sponsor
- Arcus Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-24
- Primary completion
- 2024-06-17
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.